These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Histological localization of TAG72 in gastric cancers and a clinico-pathological study of the CA72-4 serum values]. Konishi F; Matzunou H; Konishi K; Yamamichi N Gan No Rinsho; 1990 May; 36(6):691-9. PubMed ID: 2161468 [TBL] [Abstract][Full Text] [Related]
4. [Tumor markers and gastric cancer. TAG-72 is the most useful]. Fernández-Llamazares J; Piñol M; Encabo G; Gelonch J Med Clin (Barc); 1998 Dec; 111(20):800. PubMed ID: 9922976 [No Abstract] [Full Text] [Related]
5. Tumor markers in epithelial ovarian cancer. Clinical applications. Hempling RE Obstet Gynecol Clin North Am; 1994 Mar; 21(1):41-61. PubMed ID: 8015766 [TBL] [Abstract][Full Text] [Related]
7. [The value of serum tumor-associated glycoprotein 72 (TAG 72) in the diagnosis of malignancies]. Sun G Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):447-50. PubMed ID: 1303818 [TBL] [Abstract][Full Text] [Related]
8. [Tumor markers in epithelial ovarian cancer]. Di Cocco B; Calabretta F; Alghisi F; Salesi N; Bossone G Minerva Ginecol; 2003 Aug; 55(4):327-32. PubMed ID: 14581857 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of TAG-72 and CEA tumor markers in sera of patients with gastrointestinal adenocarcinomas. Guadagni F; Roselli M; Amato T; Abbolito MR; Cosimelli M; Mannella E; Greiner JW; Schlom J J Nucl Med Allied Sci; 1990; 34(4 Suppl):293-6. PubMed ID: 2092139 [No Abstract] [Full Text] [Related]
10. Evaluation of TAG-72 as a serum marker in ovarian and breast carcinoma. Esposito G; Panza N; Mansi L; De Matteis A; D'Aiuto G; Labonia V; Riccardi F; Pacilio G; Salvatore M J Nucl Med Allied Sci; 1990; 34(2):88-93. PubMed ID: 2246676 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer]. Ubukata H; Katano M; Motohashi G; Kasuga T; Takemura A; Tabuchi T; Tabuchi T Gan To Kagaku Ryoho; 2003 Oct; 30(11):1821-4. PubMed ID: 14619529 [TBL] [Abstract][Full Text] [Related]
12. Apocrine carcinoma, adenopathies, and raised TAG-72 serum tumor marker. Santos-Juanes J; Bernaldo de Quirós JF; Galache Osuna C; Sánchez del Río J; Allende MT; Folgueras MV; Soto de Delás J Dermatol Surg; 2004 Apr; 30(4 Pt 1):566-9. PubMed ID: 15056154 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of tumor-associated mucin-type glycoprotein CA 54/61 in ovarian cancers: comparison with CA 125. Suzuki M; Sekiguchi I; Tamada T Obstet Gynecol; 1990 Sep; 76(3 Pt 1):422-7. PubMed ID: 2381620 [TBL] [Abstract][Full Text] [Related]
14. Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3. Jacobs IJ; Oram DH; Bast RC Obstet Gynecol; 1992 Sep; 80(3 Pt 1):396-9. PubMed ID: 1495694 [TBL] [Abstract][Full Text] [Related]
15. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA. Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491 [TBL] [Abstract][Full Text] [Related]
16. [Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker]. Zeimet AG; Guadagni F; Marth C; Amato T; Müller-Holzner E; Huter O; Daxenbichler G; Dapunt O Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):195-9. PubMed ID: 7789707 [TBL] [Abstract][Full Text] [Related]
17. [Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases]. Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M Gan To Kagaku Ryoho; 1994 May; 21(6):823-32. PubMed ID: 8185340 [TBL] [Abstract][Full Text] [Related]
19. Serum and tissue measurements of CA72-4 in ovarian cancer patients. Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375 [TBL] [Abstract][Full Text] [Related]
20. [A clinical evaluation of the CA 72-4 serum level as a possible tumor marker]. Jibiki K; Takeda M; Abe H; Ito M; Odagiri E; Demura R; Demura H; Takizawa K Gan No Rinsho; 1990 Oct; 36(12):2146-52. PubMed ID: 2232183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]